How Weight Loss Injection Pricing Works in the UK

If you are searching for the cheapest Mounjaro in the UK, or comparing the cost of Wegovy or Saxenda, you will quickly notice that prices vary between providers. That is because the price you pay privately is not simply the cost of the medicine. It bundles the medicine itself, the clinical assessment and prescribing, ongoing support, delivery and supplies, and each provider sets its own margin. Prices also differ by dose and have changed over time, most notably with the September 2025 Mounjaro list-price rise. This guide explains each part of the price so you can compare fairly. We do not quote prices here; see our prices page for current comparisons.

Why weight loss injections are priced differently

In the UK, a private weight loss injection reaches you through a chain: the manufacturer (Eli Lilly for Mounjaro, Novo Nordisk for Wegovy and Saxenda) sells to wholesalers, who supply registered pharmacies. A prescriber, often employed by or partnered with an online pharmacy, assesses you and issues a private prescription, which the pharmacy dispenses and delivers.

Each step adds cost, and each provider decides how to structure its prices. Two providers selling the same pen at the same dose may charge different amounts because they include different services, have different overheads or take different margins.

For background on each medicine, see our hubs for Mounjaro and Wegovy, and the wider overview of weight loss injections.

The building blocks of the price

1. The medicine's list and wholesale price

Manufacturers set a UK list price for each pack. Pharmacies purchase from wholesalers, sometimes at small discounts from list price depending on volume and contracts. This wholesale cost is usually the largest single part of what you pay, and it is largely outside the provider's control.

List prices can change. Eli Lilly increased the UK list price of Mounjaro from 1 September 2025, with the steepest increases applying to higher strengths. Lilly said the original UK price had been set well below the European average to support NHS access, and that it was aligning it more closely with other developed countries. Lilly stated that prices paid by the NHS were not changing. Our article on the 2025 Mounjaro price rise covers this in detail.

2. Prescribing and clinical assessment

Weight loss injections are prescription-only medicines. Before prescribing, a registered prescriber (a doctor, pharmacist independent prescriber or nurse prescriber) must assess whether treatment is appropriate. That involves:

• checking your identity, age and BMI
• reviewing your medical history, current medicines and allergies
• screening for reasons the medicine might not be safe, such as previous pancreatitis, pregnancy or certain thyroid cancers
• checking for signs of an eating disorder

General Pharmaceutical Council (GPhC) guidance for online pharmacies, strengthened in 2025, expects providers to verify information independently for medicines such as weight loss injections, rather than relying on a questionnaire alone. That can mean video consultations, photo or video weight verification, or contact with your GP. All of this takes clinical time, which is built into the price, either as a separate consultation fee or within the medicine price.

3. Ongoing monitoring and support

Good practice involves regular check-ins: reviewing side effects, progress and whether to increase, hold or reduce the dose. Some providers include unlimited messaging with clinicians, dietitian or health-coach support, or apps. Others offer a more basic service. More support usually means a higher cost, but it may also mean safer, better-supported treatment.

4. Supplies and delivery

Injectable GLP-1 pens need to be kept refrigerated before use. Delivery therefore involves insulated, temperature-controlled packaging and tracked, often next-day courier services. Some providers include:

• pen needles (whether needles come in the medicine pack differs by product, so check the patient information leaflet)
• a sharps bin for safe disposal
• alcohol swabs

Others charge for these separately or expect you to obtain them. Our guide to the hidden costs of private treatment lists what to check.

5. The provider's margin and overheads

Pharmacies and clinical services have staff, premises, regulatory, insurance and technology costs. They also need to make a margin. Larger providers may achieve economies of scale; smaller ones may compete on service. This is the part of the price that varies most between providers.

How dose affects the price

Dose-based pricing

Each strength of Mounjaro comes in its own KwikPen containing four weekly doses, which is roughly one month's supply. Following the September 2025 change, Lilly's list prices differ across strengths, and many providers reflect this by charging more for higher doses.

Because most people move up through several doses, the starting price is not a reliable guide to the cost of treatment over months.

Dose increases are usually no more often than every four weeks, and not everyone needs or tolerates the higher doses. The decision to increase, hold or reduce is a clinical one, made by your prescriber based on response and side effects, not on cost. See the Mounjaro dosing schedule for more.

Flat pricing

Some providers charge the same amount whatever the dose. This can be simpler to budget, but it may mean paying more than you would elsewhere in the early months and less later. Neither model is inherently better; it depends on how long you expect to be treated and at what dose.

Wegovy and Saxenda

Wegovy follows a similar four-weekly step-up from 0.25mg to the 2.4mg maintenance dose, and the MHRA approved a higher 7.2mg maximum dose in January 2026 for some adults with obesity. How providers price different strengths varies. Saxenda (liraglutide) is a daily injection, and the number of pens you need each month depends on your dose. Generic liraglutide products have also become available, which may affect cost. See our Wegovy price guide and Mounjaro price guide.

Pricing models you might see

Because UK law restricts the promotion of prescription-only medicines to the public, providers are limited in how they can advertise named weight loss injections. Be cautious of anything that feels like a sales push, such as countdown timers, "limited stock" messages or offers tied to signing up quickly. Prescribing decisions should be based on clinical need, not promotions.

NHS versus private costs

On the NHS

If you are eligible for NHS treatment, you pay the standard NHS prescription charge in England, unless you are exempt. Prescriptions are free in Scotland, Wales and Northern Ireland. The NHS pays manufacturers through negotiated arrangements, which may include confidential discounts agreed as part of NICE appraisals.

NHS access is limited. NICE TA875 recommends Wegovy within specialist weight management services, and NICE TA1026 recommends Mounjaro for adults with a BMI of at least 35 and a weight-related condition, with NHS England phasing access in priority cohorts from June 2025. See Mounjaro on the NHS and private vs NHS weight loss treatment.

Privately

Private patients pay the full retail price set by their provider. Because the NHS price is negotiated separately, NHS price changes do not flow directly through to private prices, and vice versa.

Who sets private prices, and is there a cap?

There is no government cap on what private providers can charge for weight loss injections. The NHS has statutory and voluntary schemes that govern what it pays for branded medicines, but these apply to NHS supply, not to private retail prices. Private providers are free to set their own prices, subject to consumer protection law, which requires pricing to be clear, accurate and not misleading.

In practice, competition between providers, the wholesale cost and what people are prepared to pay all shape the market. That is why prices for the same medicine can differ noticeably from one provider to another, and why they can change at short notice when wholesale costs move.

Why UK prices differ from other countries

You may read that weight loss injections cost far more in the United States, or less in some other countries. International comparisons are difficult because list prices, insurance systems, rebates and confidential discounts vary hugely. The UK list price for Mounjaro was initially set relatively low, which Eli Lilly said was to avoid delays in NHS access. The September 2025 increase was framed by Lilly as bringing UK pricing closer to that of other developed countries, and was widely reported against the background of political pressure in the US over drug pricing.

The practical point for UK patients is that private prices can move in response to decisions made by manufacturers at a global level, which is another reason to plan for the possibility of price changes during treatment.

Supply, shortages and price

Between 2022 and 2024, high demand for GLP-1 medicines led to supply shortages in the UK, and the Department of Health and Social Care issued guidance asking prescribers to prioritise people with type 2 diabetes for diabetes-licensed products such as Ozempic. Supply of the weight-management products has since become more stable, but shortages of particular strengths can still happen.

When supply is tight, providers may struggle to source certain doses, prices can fluctuate and some may limit new patients. If your usual dose is unavailable, your prescriber should advise you on safe options, which might include holding your current dose or temporarily using a different strength. Never switch to a diabetes-licensed product, or to an unregulated source, without clinical advice.

Thinking through a year of treatment

Because prices vary by dose and change over time, it helps to think about a full year rather than a single month. Without using any specific figures, a typical year on a weekly injection might look like this:

• Months 1 to 4: starting dose, then step-ups every four weeks if side effects allow. Each new strength may have a different price.
• Months 4 to 6: many people reach a dose that works for them. Some continue to increase; others stay at a lower dose because it is effective and well tolerated.
• Months 6 to 12: maintenance at a steady dose, with regular reviews. Weight loss often slows and then plateaus during this period.

Adding up each month at the price of the relevant strength, plus any consultation, delivery or supply fees, gives a more realistic picture than the headline price. It is also sensible to allow for the possibility of a list-price change during the year, or of needing to pause treatment because of side effects, illness, surgery or pregnancy plans.

Your prescriber cannot predict exactly how far you will need to go up the dose schedule, but they can explain the usual pattern and what happens if you stay at a lower dose. Dose decisions should always be clinical, not financial. Our guide to Mounjaro results over time explains how weight loss typically progresses.

How to compare prices fairly

A fair comparison looks beyond the first month. These questions can help:

1. What is included? Consultation, prescriber reviews, needles, sharps bin, delivery and support.
2. What does each dose cost? Map the price across the doses you might reasonably use over six to twelve months.
3. Are there extra fees? For example, for consultations, ID checks, express delivery or changing your plan.
4. What happens after any introductory period?
5. How flexible is it? Can you pause, hold a dose or cancel without penalty?
6. Is the provider properly regulated? Check the pharmacy on the GPhC register and the prescriber on the relevant professional register.
7. How good is the clinical care? Response times, access to clinicians and clear advice on side effects.

Our prices page compares regulated providers on these service factors, and our guide to choosing an online pharmacy explains what to look for.

Why safety matters more than price

The demand for weight loss injections has led to a market in fake and unlicensed products sold through social media, messaging apps and unregistered websites, often at prices that seem too good to be true. The MHRA has repeatedly warned against buying these medicines without a prescription and has seized large quantities of falsified products. Fake pens may contain the wrong dose, a different substance or contaminants.

Signs of a legitimate UK provider include:

• a GPhC-registered pharmacy, which you can check on the GPhC register
• prescribers registered with the GMC, GPhC or NMC
• a proper consultation with identity and weight checks
• clear information about the medicine, side effects and how to get help
• willingness to share information with your GP

Our guides to getting weight loss injections online safely and fake weight loss jabs cover this in detail.

Thinking about cost over the long term

Evidence from trials such as the STEP 1 extension and SURMOUNT-4 shows that weight is often regained after GLP-1 medicines are stopped. That means many people treat obesity as a long-term condition and stay on medication for extended periods, which makes the cumulative cost more important than the monthly one. Our guide to the long-term cost of GLP-1 treatment explains how to plan, and why it helps to discuss a realistic plan, including what happens if you need to stop, with your prescriber at the outset.

If cost becomes a barrier, speak to your prescriber rather than stopping suddenly, skipping doses or switching to an unregulated source. They can discuss options, which may include holding at a lower dose if that is clinically appropriate, switching medicine, or exploring NHS eligibility.

When to speak to a professional

Talk to your GP, pharmacist or prescriber before starting a weight loss injection, before changing your dose and before stopping. They can check whether treatment is safe and suitable, and whether you might be eligible for NHS care. Do not change your dose or schedule to save money without clinical advice.

Seek urgent medical help (NHS 111, or 999 in an emergency) if you experience:

• severe, persistent abdominal pain, possibly spreading to the back, with or without vomiting (possible pancreatitis)
• pain in the upper right abdomen, fever, or yellowing of the skin or eyes (possible gallbladder problems)
• persistent vomiting or diarrhoea with signs of dehydration
• swelling of the face, lips or throat, or difficulty breathing
• any unexpected symptoms after using a pen bought from an unregulated source

Report suspected side effects or suspected fake medicines to the MHRA through the Yellow Card scheme.